Journal of Pediatric Health Care
Volume 22, Issue 1 , Pages 3-11 , January 2008

Hepatitis A: Disease Burden and Current Childhood Vaccination Strategies in the United States

References 

  1. Agarwal KS, Puliyel JM, Mathew A, Lahoti D, Gupta R. Acute pancreatitis with cholestatic hepatitis: An unusual manifestation of hepatitis A. Annals of Tropical Paediatrics. 1999;19:391–394
  2. Armstrong GL, Bell BP. Hepatitis A virus infections in the United States: Model-based estimates and implications for childhood immunization. Pediatrics. 2002;109:839–845
  3. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine. 2006;144:705–714
  4. Basaranoglu M, Balci NC, Klor HU. Gallbladder sludge and acute pancreatitis induced by acute hepatitis A. Pancreatology. 2006;6:141–144
  5. Bell BP. Global epidemiology of hepatitis A: Implications for control strategies. In:  Margolis HS,  Alter MJ,  Liang J,  Dienstag J editor. Viral hepatitis and liver disease. Atlanta: International Medical Press; 2002;p. 9–14Retrieved from http://www.cdc.gov/ncidod/diseases/hepatitis/a/global_hepA_epi.pdf
  6. Bell BP, Anderson DA, Feinstone SM. Hepatitis A virus. In:  Mandell GL,  Bennett JE,  Dolin R editor. Principles and practice of infectious diseases. 6th ed.. Philadelphia: Churchill Livingstone; 2005;p. 2162–2185
  7. Bialek SR, Thoroughman DA, Hu D, Simard EP, Chattin J, Cheek J, et al. Hepatitis A incidence and hepatitis a vaccination among American Indians and Alaska Natives, 1990-2001. American Journal of Public Health. 2004;94:996–1001
  8. Brown GR, Persley K. Hepatitis A epidemic in the elderly. Southern Medical Journal. 2002;95:826–883
  9. Centers for Disease Control and Prevention. Summary of notifiable diseases—United States, 1995. Morbidity and Mortality Weekly Report. 1995;44:1–87
  10. Centers for Disease Control and Prevention. Notice to readers: Licensure of inactivated hepatitis A vaccine and recommendations for use among international travelers. Morbidity and Mortality Weekly Report. 1995;44:559–560
  11. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report. 1996;45(RR-15):1–30
  12. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report. 1999;48(RR-12):1–37
  13. Centers for Disease Control and Prevention. Hepatitis Surveillance Report No. 60. Atlanta, GA: U.S. Department of Health and Human Services; 2005;
  14. Centers for Disease Control and Prevention. Record of the meeting of the Advisory Committee on Immunization Practices. 2005;October 26-27
  15. Centers for Disease Control and Prevention. Hepatitis A vaccination coverage among children aged 24-35 months—United States, 2003. Morbidity and Mortality Weekly Report. 2005;54:141–144
  16. Centers for Disease Control and Prevention. Notice to readers: FDA approval of Havrix (hepatitis A vaccine, inactivated) for persons aged 1-18 years. Morbidity and Mortality Weekly Report. 2005;54:1235–1236
  17. Centers for Disease Control and Prevention. Notice to readers: FDA approval of VAQTA (hepatitis A vaccine, inactivated) for children aged ≥1 year. Morbidity and Mortality Weekly Report. 2005;54:1026
  18. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report. 2006;55(RR-7):1–23
  19. Centers for Disease Control and Prevention. Hepatitis A. In: Epidemiology and prevention of vaccine-preventable diseases. 9th ed.. Atlanta, GA: Author; 2006;p. 193–206(pink book)
  20. Centers for Disease Control and Prevention. Summary of notifiable diseases—United States, 2004. Morbidity and Mortality Weekly Report. 2006;53:1–81
  21. Centers for Disease Control and Prevention. Recommended childhood and adolescent immunization schedule: United States, 2006. Morbidity and Mortality Weekly Report. 2006;54:+Q4
  22. Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. Journal of American Medical Association. 2005;294:202–210
  23. Domenech P, Palomeque A, Martinez-Gutierrez A, Vinolas N, Vela E, Jimenez R. Severe aplastic anaemia following hepatitis A. Acta Haematologica. 1986;6:227–229
  24. Elinav E, Ben-Dov IZ, Shapira Y, Daudi N, Adler R, Shouval D, et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology. 2006;130:1129–1134
  25. Erkan T, Kutlu T, Cullu F, Tumay GT. A case of vertical transmission of hepatitis A virus infection. Acta Paediatrica. 1998;87:1008–1009
  26. Fiore AE. Hepatitis A transmitted by food. Clinical Infectious Diseases. 2004;38:705–715
  27. Gall SA. Expanding the use of hepatitis vaccines in obstetrics and gynecology. American Journal of Medicine. 2005;118:96S–99S
  28. Grey M. The impact of the “Put Prevention into Practice” initiative on pediatric nurse practitioner practices. Journal of Pediatric Health Care. 1998;12:171–175
  29. Hadler SC, Webster HM, Erben JJ, Swanson JE, Maynard JE. Hepatitis A in day-care centers (A community-wide assessment). New England Journal of Medicine. 1980;302:1222–1227
  30. Hamer DH, Connor BA. Travel health knowledge, attitudes and practices among United States travelers. Journal of Travel Medicine. 2004;11:23–26
  31. Hutin YJ, Pool V, Cramer EH, Nainan OV, Weth J, Williams IT, et al. A multistate, foodborne outbreak of hepatitis A (National Hepatitis A Investigation Team). New England Journal of Medicine. 1999;340:595–602
  32. Inman RD, Hodge M, Johnston ME, Wright J, Heathcote J. Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Annals of Internal Medicine. 1986;105:700–703
  33. Jamil SM, Massry SG. Acute anuric renal failure in nonfulminant hepatitis A infection. American Journal of Nephrology. 1998;18:329–332
  34. Keeffe EB. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. American Journal of Medicine. 2005;118:21S–27S
  35. Laurence JC. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. American Journal of Medicine. 2005;118:75S–83S
  36. Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW. Frequency of illness associated with epidemic hepatitis A virus infections in adults. American Journal of Epidemiology. 1985;122:226–233
  37. Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Pediatrics. 2006;118:e602–e609
  38. Roessling G. Prefilled syringes: Innovations that meet the growing demand. ONdrugDelivery Ltd, UK. Retrieved September 11, 2006, from http://www.ondrugdelivery.com/publications/prefilled_syringes.pdf2005;
  39. Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine. 1992;10:S18–S20
  40. Sewell EC, Jacobson SH, Weniger BG. “Reverse engineering” a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines. Pediatric Infectious Disease Journal. 2001;20:S45–S56
  41. Shenoy R, Nair S, Kamath N. Thrombocytopenia in hepatitis A—an atypical presentation. Journal of Tropical Pediatrics. 2004;50:241–242
  42. Shepard CW, Ortega-Sanchez IR, Scott RD, Rosenstein NE. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Pediatrics. 2005;115:1220–1232
  43. Shroff GR, Badve SV, Joshi AG, Desai DC, Abraham P, Sirsat RA. Acute renal tubular injury with acute hepatitis A infection: is it just a coincidence?. Nephrology. 2004;9:44–46(Carlton)
  44. Staes CJ, Schlenker TL, Risk I, Cannon KG, Harris H, Pavia AT, et al. Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics. 2000;106:E54
  45. Steffen R. Changing travel-related global epidemiology of hepatitis A. American Journal of Medicine. 2005;118(Suppl 10A):46S–49S
  46. Tomida S, Matsuzaki Y, Nishi M, Ikegami T, Chiba T, Abei M, et al. Severe acute hepatitis A associated with acute pure red cell aplasia. Journal of Gastroenterology. 1996;31:612–617
  47. Tyler KL, Gross RA, Cascino GD. Unusual viral causes of transverse myelitis: Hepatitis A virus and cytomegalovirus. Neurology. 1986;36:855–858
  48. Van Damme P, Banatvala J, Fay O, Iwarson S, McMahon B, Van Herck K, et al. Hepatitis A booster vaccination: Is there a need?. Lancet. 2003;362:1065–1071
  49. Van Effelterre TP, Zink TK, Hoet BJ, Hausdorff WP, Rosenthal P. A mathematical model of hepatitis a transmission in the United States indicates value of universal childhood immunization. Clinical Infectious Diseases. 2006;43:158–164
  50. Van Herck K, Van Damme P. Prevention of hepatitis A by Havrix: A review. Expert Review of Vaccines. 2005;4:459–471
  51. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. New England Journal of Medicine. 1998;338:286–290
  52. Vesely DL, Dilley RW, Duckworth WC, Paustian FF. Hepatitis A-induced diabetes mellitus, acute renal failure, and liver failure. American Journal of the Medical Sciences. 1999;317:419–424
  53. Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. Journal of the American Medical Association. 2005;294:194–201
  54. Werblowsky-Constantini N, Livshin R, Burstein M, Zeligowski A, Tur-Kaspa R. Toxic epidermal necrolysis associated with acute cholestatic viral hepatitis A. Journal of Clinical Gastroenterology. 1989;11:691–693
  55. Wheeler C, Vogt TM, Armstrong GL, Vaughan G, Weltman A, Nainan OV, et al. An outbreak of hepatitis A associated with green onions. New England Journal of Medicine. 2005;353:890–897
  56. World Health Organization. WHO Vaccine-preventable diseases: monitoring system, 2004 global and regional summary. Retrieved September 10, 2006, form http://www.who.int/immunization_delivery/systems_policy/GlobalSummary2004.pdf2004;
  57. Zhou F, Bisgard KM, Yusuf HR, Deuson RR, Bath SK, Murphy TV. Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: An economic analysis. Pediatrics. 2002;110:653–661

PII: S0891-5245(06)00789-9

doi: 10.1016/j.pedhc.2006.12.011

Journal of Pediatric Health Care
Volume 22, Issue 1 , Pages 3-11 , January 2008

Article Tools

* Image Usage & Resolution